“Additionally, GENFIT’s diagnostic technology featured ... and was recently presented during the Late Breaking session at EASL and jointly published in the New England Journal of Medicine3 ...

Six posters have been accepted for presentation at EASL Congress mainly covering several of GENFIT's assets positioned in ACLF and, including, GENFIT's latest work on Real-World data in ACLF.

Lille (France), Cambridge (Massachusetts, United States), Zurich (Switzerland), April 28, 2025 - GENFIT (Nasdaq and Euronext ... for the Study of the Liver (EASL) on May 10, 2025 at 11.15 CET.

Lille (France), Cambridge (Massachusetts, United States), Zurich (Switzerland), June 17, 2024 - GENFIT (Nasdaq and Euronext ... for the Study of the Liver (EASL), the European Association for ...

Lille (France), Cambridge (Massachusetts, United States), Zurich (Switzerland), May 5, 2025 - GENFIT (Nasdaq and Euronext ... for the Study of the Liver (EASL) Annual Congress 2025 with six ...

(MENAFN- GlobeNewsWire - Nasdaq) Lille (France), Cambridge (Massachusetts, United States), Zurich (Switzerland), April 28, 2025 - GENFIT (Nasdaq and Euronext: GNFT ...

Six posters have been accepted for presentation at EASL Congress mainly covering several of GENFIT’s assets positioned in ACLF and, including, GENFIT’s latest work on Real-World data in ACLF. GENFIT ...